Antiphospholipid Syndrome in Pregnancy

Hematology/Oncology Clinics of North America

Volumn 22, Issue 1, 2008, Pages 107-120

  Bick, Rodger L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ALOPECIA; ALTERNATIVE MEDICINE; ANTIPHOSPHOLIPID SYNDROME; AUTHOR; BLEEDING; CONCEPTION; COST EFFECTIVENESS ANALYSIS; DELIVERY; EOSINOPHILIA; ERYTHEMA; HEMOSTASIS; HUMAN; INFERTILITY; INJECTION SITE REACTION; MATERNAL CARE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; REVIEW; SCREENING; SKIN PRURITUS; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS; UNITED STATES;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; ENOXAPARIN; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOPHILIA;

EID: 38349026776     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2007.10.008     Document Type: Review

References (49)

1. Bick R.L. Recurrent miscarriage syndrome and infertility caused by blood coagulation/platelet defects. In: Bick R.L., Frenkel E.P., Baker W.F., et al. (Eds). Hematological complications of obstetrics, pregnancy and gynecology (2006), Cambridge University Press, Cambridge (UK) 55-74
2. Bick R.L. Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defects. Hematol Oncol Clin North Am 14 (2000) 1117-1132
3. Bick R.L., and Baker W.F. Antiphospholipid syndrome and thrombosis. Semin Thromb Hemost 25 (1999) 333-350
4. Bick R.L. The antiphospholipid thrombosis syndromes: a common multidisciplinary medical problem. Clin Appl Thromb Hemost 3 (1997) 270-283
5. Scott J.R., Rote N.S., and Branch D.W. Immunological aspects of recurrent abortion and fetal death. Obstet Gynecol 70 (1987) 645-656
6. Khamashta M.A. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome. Lupus 2 Suppl 7 (1998) S162-S165
7. Amengual O., Atsumi T., Khamashta M.A., et al. Advances in antiphospholipid (Hughes') syndrome. Ann Acad Med Singap 27 (1998) 61-66
8. Bick R.L. Antiphospholipid thrombosis syndromes: etiology, pathophysiology, diagnosis and management. Int J Hematol 65 (1997) 193-198
9. Bick R.L., and Baker W.F. The antiphospholipid and thrombosis syndromes. Med Clin North Am 78 (1994) 667-684
10. Bick R.L., Arun B., and Frenkel E.P. Antiphospholipid thrombosis syndromes. Haemostasis 29 (1999) 111-134
11. Festin M.R., Limson G.M., and Maruo T. Autoimmune causes of recurrent pregnancy loss. Kobe J Med Sci 43 (1997) 143-157
12. Roussev R.G., Kaider B.D., Price D.E., et al. Laboratory evaluation of women experiencing reproductive failure. Am J of Reproductive Immunology (Copenhagen) 35 (1996) 415-420
13. Oshiro B.T., Silver R.M., Scott J.R., et al. Antiphospholipid antibodies and fetal death. Obstet Gynecol 87 (1996) 489-493
14. Granger K.A., and Farquharson R.G. Obstetric outcome in antiphospholipid syndrome. Lupus 6 (1997) 509-513
15. Borrelli A.L., Brillante M., Borzacchiello C., et al. Hemocoagulative pathology and immunological recurrent abortion. Clin Exp Obstet Gynecol 24 (1997) 39-40
16. Hellan M., Kuhnel E., Speiser W., et al. Familial lupus anticoagulant: a case report and review of the literature. Blood Coagul Fibrinolysis 9 (1998) 195-200
17. Ogasawara M., Aoki K., Matsuura E., et al. Anti beta-2-glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance. Lupus 5 (1996) 587-592
18. Zangari M., Lockwood C.J., Scher J., et al. Prothrombin activation fragment (F1.2) is increased in pregnant patients with antiphospholipid antibodies. Thromb Res 85 (1997) 177-183
19. Aznar J., and Factor V. Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion. Haematologica 84 (1999) 80-84
20. Aznar J., Villa P., Espana F., et al. Activated protein C resistance phenotype in patients with antiphospholipid antibodies. J Lab Clin Med 130 (1997) 202-208
21. Schultz D.R. Antiphospholipid antibodies: basic immunology and assays. Semin Arthritis Rheum 26 (1997) 724-739
22. Amengual O., Atsumi T., Khamashta M.A., et al. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 79 (1998) 276-281
23. Martini A., and Ravelli A. The clinical significance of antiphospholipid antibodies. Ann Med 29 (1997) 159-163
24. Bussen S.S., and Steck T. Thyroid antibodies and their relation to antithrombin antibodies, anticardiolipin antibodies and lupus anticoagulant in women with recurrent spontaneous abortions (antithyroid, anticardiolipin and antithrombin autoantibodies and lupus anticoagulant in habitual aborters). Eur J Obstet Gynecol Reprod Biol 74 (1997) 139-143
25. Rand J.H., and Wu X.X. Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome. Thromb Haemost 82 (1999) 649-654
26. Rand J.H., Wu X.X., Andree H.A., et al. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood 92 (1998) 1652-1660
27. Rauch J. Lupus anticoagulant antibodies: recognition of phospholipid-binding protein complexes. Lupus 7 Suppl 2 (1998) S29-S33
28. Rote N.S., Vogt E., DeVere G., et al. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J of Reproductive Immunology (Copenhagen) 39 (1998) 125-136
29. Vogt E., Ng A.K., and Rote N.S. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol 177 (1997) 964-972
30. Lakasing L., Campa J.S., Poston R., et al. Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome. Am J Obstet Gynecol 181 (1999) 180-189
31. Siaka C., Lambert M., Caron C., et al. Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss. Revue de Medecine Interne 20 (1999) 762-765
32. Kaburaki J., Kuwana M., Yamamoto M., et al. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 54 (1997) 209-213
33. Eschwege V., Peynaud-Debayle E., Wolf M., et al. Prevalence of antiphospholipid-related antibodies in unselected patients with history of venous thrombosis. Blood Coagul Fibrinolysis 9 (1998) 429-434
34. Silver R.M., Pierangeli S.S., Edwin S.S., et al. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol 176 (1997) 628-633
35. Branch D.W., Silver R., Pierangeli S., et al. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 89 (1997) 549-555
36. Bick R.L., and Hoppensteadt D. Recurrent miscarriage syndrome and infertility due to blood coagulation/platelet defects: a review and update. Clin Appl Thromb Hemost 11 (2005) 1-13
37. Toschi V., Motta A., Costelli C., et al. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 29 (1998) 1759-1764
38. FDA MedWatch. Lovenox (enoxaparin sodium) injection [January 9, 2002: Aventis]: warnings FDA MedWatch 1/9/2002. Available at:. http://www.fda.gov/medwatch/SAFETY/2002/jan02.htm#lovenox Accessed January 2, 2002
39. Brown H.L. Antiphospholipid antibodies and recurrent pregnancy loss. Clin Obstet Gynecol 34 (1991) 17-26
40. Perino A., Barba G., Cimino C., et al. Immunological problems in the recurrent abortion syndrome. Acta Eur Fertil 20 (1989) 199-202
41. Many A., Pauzner R., Carp H., et al. Treatment of patients with antiphospholipid antibodies during pregnancy. Am J Reprod Immunol 28 (1992) 216-218
42. Lubbe W.F., and Liggins G.C. Role of lupus anticoagulant and autoimmunity in recurrent fetal loss. Semin Reprod Endocrinol 6 (1988) 181-190
43. Lin Q. Investigation of the association between autoantibodies and recurrent abortions. Chinese J Obstet Gynecol 28 (1993) 674-679
44. Cowchock F.S., Reece E.A., Balaban D., et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 166 (1992) 1318-1323
45. Landy H.J., Kessler C., Kelly W.K., et al. Obstetric performance in patients with the lupus anticoagulant and/or anticardiolipin antibodies. Am J Perinatol 9 (1992) 146-151
46. Semprini A.E., Vucetich A., Garbo S., et al. Effect of prednisone and heparin treatment in 14 patients with poor reproductive efficiency related to lupus anticoagulant. Fetal Ther 4 Suppl 1 (1989) 73-76
47. Rosove M.H., Tabsh K., Wasserstrum N., et al. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 75 (1990) 630-634
48. Kutteh W.H., and Ermel L.D. A clinical trial for the treatment of the antiphospholipid antibody associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 35 (1996) 402-407
49. Parke A. The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses. In: Ballow M. (Ed). IVIG Therapy Today (1992), Humana Press, Inc., Totowa (NJ) 105-118